Journal article 66 views
Using Data Technology Platforms to Deliver Stakeholder Value in Healthcare
Technology | Amplify, Volume: 37, Issue: 6, Pages: 37 - 43
Swansea University Authors: Daniel Rees , Roderick Thomas , Victoria Bates, Gareth Davies
Abstract
Daniel J. Rees, Roderick A. Thomas, Victoria Bates, and Gareth Davies examine the transformational impact that healthcare-related technologies (e.g., AI, wearable sensors, clinical and genetic data) have on the healthcare and pharmaceutical industries. These technologies can potentially transform he...
Published in: | Technology | Amplify |
---|---|
Published: |
CUTTER
2024
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa67865 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
first_indexed |
2024-10-01T10:25:36Z |
---|---|
last_indexed |
2024-10-01T10:25:36Z |
id |
cronfa67865 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0" encoding="utf-8"?><rfc1807 xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema"><bib-version>v2</bib-version><id>67865</id><entry>2024-10-01</entry><title>Using Data Technology Platforms to Deliver Stakeholder Value in Healthcare</title><swanseaauthors><author><sid>daa6762111f9ebf62b9c2ec655512783</sid><ORCID>0000-0003-0372-6096</ORCID><firstname>Daniel</firstname><surname>Rees</surname><name>Daniel Rees</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>891091891b6eee412668ae216f713312</sid><ORCID>0000-0002-2792-1251</ORCID><firstname>Roderick</firstname><surname>Thomas</surname><name>Roderick Thomas</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>ec4147fc1ab793c8ef01a04d6b986b2b</sid><firstname>Victoria</firstname><surname>Bates</surname><name>Victoria Bates</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>0fa6da2da22b7dce598291b581746188</sid><ORCID>0000-0001-7872-7574</ORCID><firstname>Gareth</firstname><surname>Davies</surname><name>Gareth Davies</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2024-10-01</date><deptcode>CBAE</deptcode><abstract>Daniel J. Rees, Roderick A. Thomas, Victoria Bates, and Gareth Davies examine the transformational impact that healthcare-related technologies (e.g., AI, wearable sensors, clinical and genetic data) have on the healthcare and pharmaceutical industries. These technologies can potentially transform healthcare business processes, resulting in faster, more efficient decision-making, human-error reduction, and accelerated product development cycles that can lead to faster product launches. The authors gained insights from 48 senior managers in healthcare and pharmaceutical organizations to both identify best practices and understand the challenges related to using healthcare-related technologies and data-centric decision-making to deliver value to stakeholders. Best practices, such as governance (memorandum of understanding), incentives (monetary and nonmonetary), scalability, and collaboration between pharmaceutical makers and technology companies, are identified as key enablers. Such practices enable stakeholders to mitigate challenges like culture (trust, reputation, time, risk aversion), governance (contracts), and scalability. The article concludes with recommendations to ensure the right individuals choose tools and processes that can lead to successful partnerships and transformational initiatives for the benefit of patients, society, and the wider economy.</abstract><type>Journal Article</type><journal>Technology | Amplify</journal><volume>37</volume><journalNumber>6</journalNumber><paginationStart>37</paginationStart><paginationEnd>43</paginationEnd><publisher>CUTTER</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint/><issnElectronic/><keywords/><publishedDay>17</publishedDay><publishedMonth>7</publishedMonth><publishedYear>2024</publishedYear><publishedDate>2024-07-17</publishedDate><doi/><url/><notes/><college>COLLEGE NANME</college><department>Management School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>CBAE</DepartmentCode><institution>Swansea University</institution><apcterm>Not Required</apcterm><funders/><projectreference/><lastEdited>2024-10-01T11:25:37.7818064</lastEdited><Created>2024-10-01T11:16:35.3388612</Created><path><level id="1">Faculty of Humanities and Social Sciences</level><level id="2">School of Management - Business Management</level></path><authors><author><firstname>Daniel</firstname><surname>Rees</surname><orcid>0000-0003-0372-6096</orcid><order>1</order></author><author><firstname>Roderick</firstname><surname>Thomas</surname><orcid>0000-0002-2792-1251</orcid><order>2</order></author><author><firstname>Victoria</firstname><surname>Bates</surname><order>3</order></author><author><firstname>Gareth</firstname><surname>Davies</surname><orcid>0000-0001-7872-7574</orcid><order>4</order></author></authors><documents/><OutputDurs/></rfc1807> |
spelling |
v2 67865 2024-10-01 Using Data Technology Platforms to Deliver Stakeholder Value in Healthcare daa6762111f9ebf62b9c2ec655512783 0000-0003-0372-6096 Daniel Rees Daniel Rees true false 891091891b6eee412668ae216f713312 0000-0002-2792-1251 Roderick Thomas Roderick Thomas true false ec4147fc1ab793c8ef01a04d6b986b2b Victoria Bates Victoria Bates true false 0fa6da2da22b7dce598291b581746188 0000-0001-7872-7574 Gareth Davies Gareth Davies true false 2024-10-01 CBAE Daniel J. Rees, Roderick A. Thomas, Victoria Bates, and Gareth Davies examine the transformational impact that healthcare-related technologies (e.g., AI, wearable sensors, clinical and genetic data) have on the healthcare and pharmaceutical industries. These technologies can potentially transform healthcare business processes, resulting in faster, more efficient decision-making, human-error reduction, and accelerated product development cycles that can lead to faster product launches. The authors gained insights from 48 senior managers in healthcare and pharmaceutical organizations to both identify best practices and understand the challenges related to using healthcare-related technologies and data-centric decision-making to deliver value to stakeholders. Best practices, such as governance (memorandum of understanding), incentives (monetary and nonmonetary), scalability, and collaboration between pharmaceutical makers and technology companies, are identified as key enablers. Such practices enable stakeholders to mitigate challenges like culture (trust, reputation, time, risk aversion), governance (contracts), and scalability. The article concludes with recommendations to ensure the right individuals choose tools and processes that can lead to successful partnerships and transformational initiatives for the benefit of patients, society, and the wider economy. Journal Article Technology | Amplify 37 6 37 43 CUTTER 17 7 2024 2024-07-17 COLLEGE NANME Management School COLLEGE CODE CBAE Swansea University Not Required 2024-10-01T11:25:37.7818064 2024-10-01T11:16:35.3388612 Faculty of Humanities and Social Sciences School of Management - Business Management Daniel Rees 0000-0003-0372-6096 1 Roderick Thomas 0000-0002-2792-1251 2 Victoria Bates 3 Gareth Davies 0000-0001-7872-7574 4 |
title |
Using Data Technology Platforms to Deliver Stakeholder Value in Healthcare |
spellingShingle |
Using Data Technology Platforms to Deliver Stakeholder Value in Healthcare Daniel Rees Roderick Thomas Victoria Bates Gareth Davies |
title_short |
Using Data Technology Platforms to Deliver Stakeholder Value in Healthcare |
title_full |
Using Data Technology Platforms to Deliver Stakeholder Value in Healthcare |
title_fullStr |
Using Data Technology Platforms to Deliver Stakeholder Value in Healthcare |
title_full_unstemmed |
Using Data Technology Platforms to Deliver Stakeholder Value in Healthcare |
title_sort |
Using Data Technology Platforms to Deliver Stakeholder Value in Healthcare |
author_id_str_mv |
daa6762111f9ebf62b9c2ec655512783 891091891b6eee412668ae216f713312 ec4147fc1ab793c8ef01a04d6b986b2b 0fa6da2da22b7dce598291b581746188 |
author_id_fullname_str_mv |
daa6762111f9ebf62b9c2ec655512783_***_Daniel Rees 891091891b6eee412668ae216f713312_***_Roderick Thomas ec4147fc1ab793c8ef01a04d6b986b2b_***_Victoria Bates 0fa6da2da22b7dce598291b581746188_***_Gareth Davies |
author |
Daniel Rees Roderick Thomas Victoria Bates Gareth Davies |
author2 |
Daniel Rees Roderick Thomas Victoria Bates Gareth Davies |
format |
Journal article |
container_title |
Technology | Amplify |
container_volume |
37 |
container_issue |
6 |
container_start_page |
37 |
publishDate |
2024 |
institution |
Swansea University |
publisher |
CUTTER |
college_str |
Faculty of Humanities and Social Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofhumanitiesandsocialsciences |
hierarchy_top_title |
Faculty of Humanities and Social Sciences |
hierarchy_parent_id |
facultyofhumanitiesandsocialsciences |
hierarchy_parent_title |
Faculty of Humanities and Social Sciences |
department_str |
School of Management - Business Management{{{_:::_}}}Faculty of Humanities and Social Sciences{{{_:::_}}}School of Management - Business Management |
document_store_str |
0 |
active_str |
0 |
description |
Daniel J. Rees, Roderick A. Thomas, Victoria Bates, and Gareth Davies examine the transformational impact that healthcare-related technologies (e.g., AI, wearable sensors, clinical and genetic data) have on the healthcare and pharmaceutical industries. These technologies can potentially transform healthcare business processes, resulting in faster, more efficient decision-making, human-error reduction, and accelerated product development cycles that can lead to faster product launches. The authors gained insights from 48 senior managers in healthcare and pharmaceutical organizations to both identify best practices and understand the challenges related to using healthcare-related technologies and data-centric decision-making to deliver value to stakeholders. Best practices, such as governance (memorandum of understanding), incentives (monetary and nonmonetary), scalability, and collaboration between pharmaceutical makers and technology companies, are identified as key enablers. Such practices enable stakeholders to mitigate challenges like culture (trust, reputation, time, risk aversion), governance (contracts), and scalability. The article concludes with recommendations to ensure the right individuals choose tools and processes that can lead to successful partnerships and transformational initiatives for the benefit of patients, society, and the wider economy. |
published_date |
2024-07-17T11:25:36Z |
_version_ |
1811706897388011520 |
score |
11.037603 |